Back to News
Market Impact: 0.15
XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers
Source: globenewswire.com
Management & Governance
XBiotech's board elected Jan-Paul Simard as Co-Chief Executive Officer alongside CEO Dr. Sushma Shivaswamy, effective Oct. 23, 2026. The announcement provides no further details on the appointment or its expected business impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
XBIT0.10
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- ‘It wasn’t me, and I don’t think it was Elon’: Trump and his cabinet send mixed messages about what led to Ukraine’s Starshield interruptions
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%
- Volvo Cars posts Q3 loss of 3.7 billion crowns, to cut 2,500 jobs
- Expion Energy amends private placement terms, updates convertible debenture agreement
- Innventure receives Nasdaq notice for minimum bid price non-compliance
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Software for Buy-Side Teams: Build the Research Stack
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit